RA83 treatment of allo-MLR preserves T... | American Society of Hematology

RA83 treatment of allo-MLR preserves T cell anti-CMV immunity

RA83 treatment of allo-MLR preserves T cell anti-CMV immunity

This Feature Is Available To Subscribers Only

Sign In or Create an Account